Ergänzende Abb. S6 aus Endokrine Therapie synergiert mit SMAC-Mimetika, um die Antigenpräsentation und Tumorrückbildung bei hormonrezeptorpositivem Brustkrebs zu verstärken

Hermida‐Prado et al. (Mon,) untersuchten diese Fragestellung.

www.synapsesocial.com/papers/68e587eeb6db643587523dc5 — DOI: https://doi.org/10.1158/0008-5472.27028615.v1

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. Supplementary Fig. S6 from Endocrine therapy synergizes with SMAC mimetics to potentiate antigen presentation and tumor regression in hormone receptor-positive breast cancer· 2024
2. Supplementary Fig. S5 from Endocrine therapy synergizes with SMAC mimetics to potentiate antigen presentation and tumor regression in hormone receptor-positive breast cancer· 2024
3. Supplementary Fig. S5 from Endocrine therapy synergizes with SMAC mimetics to potentiate antigen presentation and tumor regression in hormone receptor-positive breast cancer· 2024
4. Supplementary Fig. S1 from Endocrine therapy synergizes with SMAC mimetics to potentiate antigen presentation and tumor regression in hormone receptor-positive breast cancer· 2024
5. Supplementary Fig. S1 from Endocrine therapy synergizes with SMAC mimetics to potentiate antigen presentation and tumor regression in hormone receptor-positive breast cancer· 2024